Vontobel Holding’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,735
| Closed | -$690K | – | 1100 |
|
|
2024
Q3 | $690K | Sell |
29,735
-989
| -3% | -$23K | ﹤0.01% | 691 |
|
|
2024
Q2 | $748K | Buy |
+30,724
| New | +$748K | ﹤0.01% | 656 |
|
|
2023
Q4 | – | Sell |
-40,659
| Closed | -$1.04M | – | 1109 |
|
|
2023
Q3 | $1.04M | Sell |
40,659
-1,042
| -2% | -$26.6K | 0.01% | 571 |
|
|
2023
Q2 | $1.2M | Sell |
41,701
-15,468
| -27% | -$444K | 0.01% | 556 |
|
|
2023
Q1 | $1.37M | Sell |
57,169
-8,689
| -13% | -$208K | 0.01% | 508 |
|
|
2022
Q4 | $1.12M | Sell |
65,858
-6,994
| -10% | -$119K | 0.01% | 548 |
|
|
2022
Q3 | $1.08M | Sell |
72,852
-3,958
| -5% | -$58.7K | 0.01% | 526 |
|
|
2022
Q2 | $1.21M | Buy |
76,810
+38,307
| +99% | +$603K | 0.01% | 498 |
|
|
2022
Q1 | $1.04M | Sell |
38,503
-1,515
| -4% | -$40.8K | 0.01% | 611 |
|
|
2021
Q4 | $1.48M | Sell |
40,018
-149
| -0.4% | -$5.51K | 0.01% | 530 |
|
|
2021
Q3 | $1.92M | Buy |
40,167
+1,015
| +3% | +$48.5K | 0.02% | 449 |
|
|
2021
Q2 | $1.33M | Buy |
+39,152
| New | +$1.33M | 0.01% | 528 |
|